张瑶,刘学军.慢性阻塞性肺疾病合并肺癌发病机制的研究进展[J].中华老年多器官疾病杂志,2022,21(1):76~80 |
慢性阻塞性肺疾病合并肺癌发病机制的研究进展 |
Research pregress of pathogenesis of chronic obstructive pulmonary disease complicated with lung cancer |
投稿时间:2020-12-03 |
DOI:10.11915/j.issn.1671-5403.2022.01.017 |
中文关键词: 肺疾病,慢性阻塞性 肺癌 发病机制 |
英文关键词:pulmonary disease, chronic obstructive lung cancer pathogenesis Corresponding author:LIU Xue-Jun, E-mail:lxj20041205@sina.com〖FL |
基金项目: |
|
摘要点击次数: 200 |
全文下载次数: 332 |
中文摘要: |
据统计,目前慢性阻塞性肺疾病(COPD)在全球40岁以上人群中发病率高达9%~10%。而世界卫生组织最新数据显示,肺癌发病率占全球新发癌症的11.6%,病死率达18.4%,是中国乃至全球发病率和病死率最高的癌症。COPD合并肺癌的年发病率为16.7%,且仍在上升。COPD合并肺癌治疗难度大,需在两种疾病基础上考虑治疗方案,病死率高,给医疗资源带来极大负担。COPD合并肺癌的发病机制复杂,且COPD本身就是肺癌发生的危险因素。本文对近年来COPD合并肺癌发病机制的研究进展进行综述。 |
英文摘要: |
According to statistics, the global incidence of chronic obstruction pulmonary disease (COPD) in the population aged over 40 years old is as high as 9%-10% at present. According to the latest data by Word Health Organization, lung cancer accounts for 11.6% of all new cancer cases in the world, with a case fatality rate of 18.4%. The lung cancer has the highest incidence rate and case fatality rate in China and even in the world. The annual incidence of COPD with lung cancer is 16.7% and is still rising. COPD with lung cancer is difficult to treat because a treatment plan should be considered both diseases. With a high fatality rate, the comorbidity poses a great burden on medical resources. The pathogenesis of COPD with lung cancer is complex, and COPD itself is a risk factor for lung cancer. In this paper, we reviewed the recent progress in the pathogenesis of COPD with lung cancer. |
查看全文
下载PDF阅读器 |
关闭 |
|
|
|